Loading insider details...
Beta
Latest Form 4 (Sep 10, 2026): Exercise/Conversion of 17,500 BCAX shares, $66.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 10, 2026 | Bicara Therapeutics Inc. (BCAX) | Exercise/Conversion | 17,500 | $66.3K |
| Aug 12, 2026 | Bicara Therapeutics Inc. (BCAX) | Exercise/Conversion | 18,750 | $71.1K |
| Jul 10, 2026 | Bicara Therapeutics Inc. (BCAX) | Exercise/Conversion | 18,750 | $71.1K |
| May 18, 2026 | Bicara Therapeutics Inc. (BCAX) | Exercise/Conversion | 8,000 | $30.3K |
| Apr 17, 2026 | Bicara Therapeutics Inc. (BCAX) | Exercise/Conversion | 8,000 | $30.3K |
| Mar 17, 2026 | Bicara Therapeutics Inc. (BCAX) | Exercise/Conversion | 8,000 | $30.3K |
| Mar 6, 2026 | Bicara Therapeutics Inc. (BCAX) | Exercise/Conversion | 12,892 | $48.9K |
| Feb 27, 2026 | Bicara Therapeutics Inc. (BCAX) | Exercise/Conversion | 3,108 | $11.8K |
| Feb 4, 2026 | Bicara Therapeutics Inc. (BCAX) | Grant/Award | 300,000 | n/a |
| Jan 26, 2026 | Bicara Therapeutics Inc. (BCAX) | Sale | 3,828 | $69.3K |